Improving access patency: pre-end-stage renal disease strategies.

  • S J Schwab
  • Published 1998 in
    Journal of the American Society of Nephrology…


Hemodialysis vascular access has emerged as a major cause of patient morbidity and cost in the end-stage renal disease (ESRD) program. It is currently estimated that the maintenance and placement of ESRD vascular access may account for up to 25% of the ESRD budget and the responsible for up to 25% of all hospital stays. The National Kidney Foundation… (More)


  • Presentations referencing similar topics